8
Oct
2024

YUNGJIN PHARM. CO. LTD.

Exhibitor at CPHI Milan 2024 stand 4A82, API
About Us

Since its establishment in 1952, Yungjin Pharm. Co., Ltd. has been enjoying the privilege of playing a major role as a forerunner in the Korean pharmaceutical industry for over half a century. Based on our long-term goal, we strive for further growth and expansion. Strong alliance with the worldwide pharmaceutical companies allows us to expand our market into the worldwide and cope with the challenging environment of global pharmaceutical industry. Through active involvement in R&D activities, quality management and overseas business, we wi...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Licensee
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4A82, API

Products Featured at CPHI Milan 2024

  • Candesartan Cilexetil API / Tab

    Product Candesartan Cilexetil API / Tab

    Yungjin Pharma offers a range of products which includes candesartan cilexetil. Specification: JP. Description: White crystalline powder. Assay: 99.0 ~ 101.0 % (as anhydrous basis). Packaging: 5, 10, 25 kg, Fiber drum. Candesartan is an antihypertensive in the angiotensin II receptor antagonist class. Cont...
  • Nintedanib API/Tab

    Product Nintedanib API/Tab

    Used for the treatment of idiopathic pulmonary fibrosis and along with other medications for some types of non-small-cell lung cancer
  • Cefmetazole Sodium / Inj

    Product Cefmetazole Sodium / Inj

    cephamycin antibiotic, usually grouped with the second-generation cephalosporins
  • Cefditoren pivoxil / Tab / Fine granule

    Product Cefditoren pivoxil / Tab / Fine granule

    An antibiotic used to treat infections caused by Gram-positive and Gram-negative bacteria that are resistant to other antibiotics. It is mainly used for treatment of community acquired pneumonia. It is taken by mouth and is in the cephalosporin family ...
  • Baroscon Double action syspension

    Product Baroscon Double action syspension

    Relieve acidreflux, heartburn, indigestion, excuess stomach acid

YUNGJIN PHARM. CO. LTD. Resources (1)

  • OVERVIEW

    Video OVERVIEW

    "Improvement of world health advances through Globalization and Partnerships"

    Company name : Yungjin Pharm. Co., Ltd
    CEO : Chae Joon, Lee
    Location : 13, Olympic-ro 35da-gil, Songpa-gu, Seoul, Korea
    Foundation date : October 10, 1952
    Representative products: Cephalosporin Antibiotic, Antipsychotic, Cardiovascular, Total Nutrition, and etc.


    Yungjin Pharm. Co., Ltd was established in 1952, has been playing a major role as a forerunner in the Korean pharmaceutical industry for half a century. With our inspiring mission statement, "To relieve the suffering of mankind from diseases with our innovative, effective and safe pharmaceutical products", we have shown our
    successful contribution not only within Korea, but also through global expansion. As a result, we have received a total of 25 awards including the President Award for Superior Product Development, the Prime Minister Award, Industry Award and many more. These accomplishments demonstrate our sustainability and commitment to the development of innovative products and business excellence in both overseas and domestic segments.

    2021-10-18